Rwanda Food and Drugs Authority, Kigali, Rwanda.
Center for One Health, University of Global Health Equity, Butaro, Rwanda.
PLoS One. 2024 Mar 7;19(3):e0299917. doi: 10.1371/journal.pone.0299917. eCollection 2024.
Estimating antibiotic consumption in animals is fundamental to guiding decision-making and research on controlling the emergence and spread of antibiotic-resistant bacteria in humans, animals, and the environment. This study aimed to establish importation trends of antibiotics for veterinary use in Rwanda between 2019 and 2021. Data was collected from the Rwanda Food and Drugs Authority's database. Quantities of imported antibiotic active ingredients were computed using the information extracted from the issued import licenses. These quantities were subsequently adjusted per animal biomass. In total, 35,291.4 kg of antibiotics were imported into Rwanda between 2019 and 2021, with an annual mean of 11,763.8 ± 1,486.9 kg. The adjustment of imported quantities of antibiotics per animal biomass revealed that 29.1 mg/kg, 24.3 mg/kg, and 30.3 mg/kg were imported in 2019, 2020, and 2021 respectively. A slight but not statistically significant decline in antibiotic importation was noted in 2020 (p-value = 0.547). Most of the imported antibiotics were indicated to be used in food-producing animals (35,253.8 kg or 99.9% of the imported antibiotics). Tetracyclines (17,768.6 kg or 50.3%), followed by sulfonamides (7,865.0 kg or 22.3%) and aminoglycosides (4,071.1 kg or 11.5%), were the most imported antibiotics over the studied period. It was noted that 78.9% of the imported antibiotics were categorized as highly important antimicrobials for human medicine. This study established a generalized overview of the importation of antibiotics for veterinary use in Rwanda. These results can serve as guidance for the control of antibiotic misuse. They can be used to make a correlation between antibiotic importation, antibiotic consumption, and the occurrence of antibiotic resistance in the country.
估算动物的抗生素使用量对于指导人类、动物和环境中抗生素耐药菌的出现和传播的决策和研究至关重要。本研究旨在建立 2019 年至 2021 年期间卢旺达进口兽用抗生素的趋势。数据来自卢旺达食品和药物管理局的数据库。从颁发的进口许可证中提取信息,计算进口抗生素活性成分的数量。这些数量随后按动物生物量进行调整。2019 年至 2021 年期间,卢旺达共进口 35291.4 千克抗生素,年均 11763.8±1486.9 千克。按动物生物量调整进口抗生素数量后发现,2019 年、2020 年和 2021 年分别进口了 29.1、24.3 和 30.3 毫克/千克。2020 年抗生素进口量略有下降,但无统计学意义(p 值=0.547)。进口的抗生素大部分用于食用动物(35253.8 千克或进口抗生素的 99.9%)。四环素(17768.6 千克或 50.3%)、磺胺类(7865.0 千克或 22.3%)和氨基糖苷类(4071.1 千克或 11.5%)是研究期间进口最多的抗生素。值得注意的是,78.9%的进口抗生素被归类为人类医学高度重要的抗菌药物。本研究建立了卢旺达进口兽用抗生素的总体概述。这些结果可作为控制抗生素滥用的指导。它们可用于在该国抗生素进口、抗生素消耗和抗生素耐药性发生之间建立相关性。